Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (Q34304341)

1 August 2017

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (English)

1 reference

1 August 2017

0 references

0 references

0 references

14

1 reference

1 August 2017

Judith Nottage

3

0 references

Amanda Feilding

object named as

Amanda Feilding

11

0 references

James Stone

object named as

James M Stone

7

0 references

Robin Murray

object named as

Robin M Murray

13

0 references

author name string

Amir Englund

1

1 reference

1 August 2017

Paul D Morrison

2

1 reference

1 August 2017

Dominic Hague

4

1 reference

1 August 2017

Fergus Kane

5

1 reference

1 August 2017

Stefania Bonaccorso

6

1 reference

1 August 2017

Avi Reichenberg

8

1 reference

1 August 2017

Rudolf Brenneisen

9

1 reference

1 August 2017

David Holt

10

1 reference

1 August 2017

Lucy Walker

12

1 reference

1 August 2017

language of work or name

English

0 references

publication date

5 October 2012

1 reference

Journal of Psychopharmacology

1 August 2017

1 reference

1 August 2017

27

1 reference

1 August 2017

1

1 reference

1 August 2017

19-27

1 reference

Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study

1 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Cannabis and psychosis/schizophrenia: human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

High-potency cannabis and the risk of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

A measure of state persecutory ideation for experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Measuring ideas of persecution and social reference: the Green et al. Paranoid Thought Scales (GPTS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Cannabinoids attenuate hippocampal γ oscillations by suppressing excitatory synaptic input onto CA3 pyramidal neurons and fast spiking basket cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Does olanzapine inhibit the psychomimetic effects of Δ⁹-tetrahydrocannabinol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Different effects of nabilone and cannabidiol on binocular depth inversion in Man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Central nervous system effects of haloperidol on THC in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Inequalities in healthcare provision for people with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Cannabis, the mind and society: the hash realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

(-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

The acute effects of cannabinoids on memory in humans: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Alteration of theta timescale dynamics of hippocampal place cells by a cannabinoid is associated with memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Cannabinoids reveal importance of spike timing coordination in hippocampal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Cannabis with high cannabidiol content is associated with fewer psychotic experiences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Cannabinoids and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Can recreational doses of THC produce significant dopamine release in the human striatum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Communication breakdown: delta-9 tetrahydrocannabinol effects on pre-speech neural coherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881112460109

21 January 2018

Identifiers

DOI

10.1177/0269881112460109

1 reference

1 August 2017

1 reference